Oncology News | pharmaphorum

News

Harpoon and Gossamer sneak out IPOs before potential SEC shu...

Immunotherapy specialist Harpoon Therapeutics has joined a group of biotechs that have sneaked out IPOs before another potential US government shutdown this weekend that could prevent furth

News

AZ's CEO dismisses "fake news" about his imminent departure

AstraZeneca’s CEO Pascal Soriot has dismissed continued rumours about his departure as “fake news” as the company announced full year results showing sales growth for the first time in a de

News

Packaged Pills in aluminium blisters stacked on each other

Clinigen buys remaining rights to Novartis cancer drug

UK pharma Clinigen is to buy the remaining rights to Novartis’ cancer drug Proleukin, in a deal worth up to $210 million.

News

Merck's Keytruda gets boost in kidney and head and neck canc...

Merck & Co and its cancer immunotherapy Keytruda has gained a double boost in its tussle with rival Bristol-Myers Squibb, with positive results in kidney cancer, and the promise of an F

News